Cho Sung Yeon, Park June Whan, An Hyoseok, Ko Hyun Ju, Kim Hyuk, Choi Jin Kyu, Choi Sun Young, Kim Sung Min, Ko Eun Jung, Kim Beom Joon
AMOREPACIFIC R&D Unit, Yongin-si, Korea.
AESTURA Corp., Seoul, Korea.
J Cosmet Dermatol. 2018 Jun;17(3):347-354. doi: 10.1111/jocd.12560. Epub 2018 Apr 23.
Infraorbital region is one of the most important regions that show the signs of aging. In recent years, hyaluronic acid (HA) fillers have been used to correct this region for esthetic treatments. Although HA fillers with various physical properties are used, limited research has been performed to compare their efficacy.
We aimed to compare three HA fillers to determine which is the most appropriate filler for the correction of the infraorbital region and evaluate the correction of such by performing a clinical test using CLEVIEL Fine.
We performed in vitro and in vivo tests using one new HA filler and two other commercial HA fillers. We compared the rheological properties, resistance to degradation, and in vivo duration test results of the three fillers. Nine patients participated in the clinical test using CLEVIEL Fine for 24 weeks.
CLEVIEL Fine showed good rheological and physical characteristics for the infraorbital region. It had a low elasticity and cohesiveness, low incidence of postinjection swelling, high tanδ, narrow particle distribution, and small particle size. Further, it showed better resistance to the enzymes and radicals in the in vitro test than the other two HA fillers and a similar duration in the mouse test. In the clinical test, all patients showed good elasticity and hydration in the infraorbital region for 24 weeks.
CLEVIEL Fine was proven to be safe and effective based on the in vitro, in vivo, and clinical study results.
眶下区域是显示衰老迹象的最重要区域之一。近年来,透明质酸(HA)填充剂已被用于该区域的美容治疗。尽管使用了具有各种物理特性的HA填充剂,但比较它们疗效的研究有限。
我们旨在比较三种HA填充剂,以确定哪种是矫正眶下区域最合适的填充剂,并通过使用CLEVIEL Fine进行临床试验来评估其矫正效果。
我们使用一种新型HA填充剂和另外两种市售HA填充剂进行了体外和体内测试。我们比较了这三种填充剂的流变学特性、抗降解性和体内持续时间测试结果。九名患者参与了使用CLEVIEL Fine进行的为期24周的临床试验。
CLEVIEL Fine在眶下区域显示出良好的流变学和物理特性。它具有低弹性和内聚性、注射后肿胀发生率低、损耗因子高、颗粒分布窄和粒径小的特点。此外,在体外测试中,它比其他两种HA填充剂对酶和自由基的抵抗力更强,在小鼠测试中的持续时间相似。在临床试验中,所有患者在24周内眶下区域均显示出良好的弹性和水合作用。
根据体外、体内和临床研究结果,CLEVIEL Fine被证明是安全有效的。